We are live on ! Find out more
THRN

Thorne Healthtech, Inc. Common Stock
THRN

Delisted

THRN was delisted on the 13th of October, 2023.

Back to rankings

0 hedge funds and large institutions have $0 invested in Thorne Healthtech, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 59 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 59 → 0 (-59)

100% less capital invested

Capital invested by funds: $82.9M → $0 (-$82.9M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 59

Holders
–
Holders Change
-59
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
59
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
GCL
Glazer Capital LLC
New York
-$13.6M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$8.77M
3
GF
Gabelli Funds
New York
-$8.52M
4
BlackRock
BlackRock
New York
-$7.47M
5
BCM
Beryl Capital Management
California
-$6.36M
Name Holding Trade Value Shares
Change 		Change in
Stake
GCL
1
Glazer Capital LLC
New York
– -$13.6M -1,330,841 Closed
Vanguard Group
2
Vanguard Group
Pennsylvania
– -$8.77M -860,553 Closed
GF
3
Gabelli Funds
New York
– -$8.52M -835,961 Closed
BlackRock
4
BlackRock
New York
– -$7.47M -733,214 Closed
BCM
5
Beryl Capital Management
California
– -$6.36M -623,775 Closed
AAM
6
Alpine Associates Management
Florida
– -$6.23M -611,300 Closed
Qube Research & Technologies (QRT)
7
Qube Research & Technologies (QRT)
United Kingdom
– -$3.31M -325,145 Closed
Geode Capital Management
8
Geode Capital Management
Massachusetts
– -$3.21M -314,864 Closed
CAM
9
Cresset Asset Management
Illinois
– -$2.91M -285,207 Closed
Goldman Sachs
10
Goldman Sachs
New York
– -$2.76M -270,851 Closed
State Street
11
State Street
Massachusetts
– -$2.4M -235,863 Closed
NYLIM
12
New York Life Investment Management
New York
– -$1.64M -160,550 Closed
GCIA
13
Gabelli & Co Investment Advisers
New York
– -$1.46M -142,800 Closed
UBS Group
14
UBS Group
Switzerland
– -$1.27M -124,779 Closed
Northern Trust
15
Northern Trust
Illinois
– -$1.19M -116,661 Closed
GI
16
GAMCO Investors
Connecticut
– -$1.09M -107,375 Closed
WIC
17
Water Island Capital
New York
– -$1.02M -99,697 Closed
PCM
18
PenderFund Capital Management
British Columbia, Canada
– -$1.1M -79,830 Closed
Bank of New York Mellon
19
Bank of New York Mellon
New York
– -$794K -77,948 Closed
Bank of America
20
Bank of America
North Carolina
– -$709K -69,582 Closed
BCM
21
BCK Capital Management
Connecticut
– -$693K -68,000 Closed
Morgan Stanley
22
Morgan Stanley
New York
– -$619K -60,740 Closed
N
23
Natixis
France
– -$611K -60,000 Closed
Barclays
24
Barclays
United Kingdom
– -$521K -51,089 Closed
Squarepoint
25
Squarepoint
New York
– -$496K -48,667 Closed
1
2 3

THRN Hedge Fund Activity: Q4 2023 in Review

0 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Thorne Healthtech, Inc. Common Stock (THRN) for Q4 2023, worth a combined $0 — down 100% from $82.9M a quarter earlier.

Sellers outnumbered buyers: 59 funds closed out of THRN and 0 opened new positions — a net loss of 59 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Glazer Capital LLC, exiting entirely with an estimated $13.6M sold.

  • 0 institutional investors held Thorne Healthtech, Inc. Common Stock (THRN) as of Q4 2023, down from 59 in Q3 2023.
  • Funds reported $0 of Thorne Healthtech, Inc. Common Stock stock for Q4 2023, down 100% quarter-over-quarter.
  • 0 funds opened new Thorne Healthtech, Inc. Common Stock positions in Q4 2023 and 59 closed out, a net change of -59 holders.
  • The largest Thorne Healthtech, Inc. Common Stock seller in Q4 2023 was Glazer Capital LLC, an estimated $13.6M sold.

Based on aggregated 13F filings for Q4 2023.